Two Sigma Advisers’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-330,887
| Closed | -$7.85M | – | 2697 |
|
|
2023
Q3 | $7.85M | Sell |
330,887
-20,600
| -6% | -$388K | 0.02% | 560 |
|
|
2023
Q2 | $5.7M | Sell |
351,487
-46,000
| -12% | -$762K | 0.01% | 706 |
|
|
2023
Q1 | $6.92M | Buy |
397,487
+4,200
| +1% | +$75.5K | 0.02% | 681 |
|
|
2022
Q4 | $7.39M | Buy |
393,287
+79,100
| +25% | +$1.52M | 0.02% | 609 |
|
|
2022
Q3 | $5.56M | Sell |
314,187
-11,500
| -4% | -$200K | 0.02% | 688 |
|
|
2022
Q2 | $5.68M | Buy |
325,687
+5,700
| +2% | +$109K | 0.02% | 712 |
|
|
2022
Q1 | $6.69M | Sell |
319,987
-83,700
| -21% | -$1.6M | 0.02% | 680 |
|
|
2021
Q4 | $7.18M | Buy |
403,687
+72,400
| +22% | +$1.16M | 0.02% | 625 |
|
|
2021
Q3 | $4.67M | Sell |
331,287
-2,600
| -0.8% | -$40.4K | 0.01% | 815 |
|
|
2021
Q2 | $5.54M | Buy |
333,887
+174,500
| +109% | +$3.13M | 0.01% | 815 |
|
|
2021
Q1 | $2.88M | Sell |
159,387
-10,400
| -6% | -$205K | 0.01% | 1097 |
|
|
2020
Q4 | $3.1M | Sell |
169,787
-27,200
| -14% | -$431K | 0.01% | 1045 |
|
|
2020
Q3 | $2.51M | Sell |
196,987
-9,802
| -5% | -$125K | 0.01% | 1045 |
|
|
2020
Q2 | $2.27M | Buy |
206,789
+105,400
| +104% | +$1.09M | 0.01% | 1139 |
|
|
2020
Q1 | $1.06M | Buy |
101,389
+60,100
| +146% | +$775K | ﹤0.01% | 1456 |
|
|
2019
Q4 | $664K | Sell |
41,289
-3,200
| -7% | -$52.9K | ﹤0.01% | 1754 |
|
|
2019
Q3 | $697K | Sell |
44,489
-22,400
| -33% | -$373K | ﹤0.01% | 1583 |
|
|
2019
Q2 | $1.33M | Sell |
66,889
-35,200
| -34% | -$657K | ﹤0.01% | 1387 |
|
|
2019
Q1 | $1.72M | Buy |
102,089
+100
| +0.1% | +$1.73K | ﹤0.01% | 1284 |
|
|
2018
Q4 | $1.54M | Sell |
101,989
-22,447
| -18% | -$385K | ﹤0.01% | 1298 |
|
|
2018
Q3 | $2.5M | Sell |
124,436
-39,900
| -24% | -$846K | 0.01% | 1128 |
|
|
2018
Q2 | $3.21M | Sell |
164,336
-40,400
| -20% | -$639K | 0.01% | 1068 |
|
|
2018
Q1 | $2.79M | Sell |
204,736
-40,300
| -16% | -$531K | 0.01% | 1083 |
|
|
2017
Q4 | $3.33M | Sell |
245,036
-20,748
| -8% | -$298K | 0.01% | 1011 |
|
|
2017
Q3 | $4.18M | Buy |
265,784
+190
| +0.1% | +$3.07K | 0.01% | 871 |
|
|
2017
Q2 | $4.57M | Buy |
265,594
+958
| +0.4% | +$14.6K | 0.02% | 793 |
|
|
2017
Q1 | $4.03M | Buy |
264,636
+16,364
| +7% | +$241K | 0.01% | 909 |
|
|
2016
Q4 | $3.27M | Buy |
248,272
+104,183
| +72% | +$1.33M | 0.01% | 928 |
|
|
2016
Q3 | $1.63M | Buy |
144,089
+500
| +0.3% | +$6K | 0.01% | 1118 |
|
|
2016
Q2 | $1.71M | Buy |
143,589
+1,700
| +1% | +$22.9K | 0.01% | 927 |
|
|
2016
Q1 | $2.16M | Sell |
141,889
-29,900
| -17% | -$454K | 0.01% | 776 |
|
|
2015
Q4 | $2.77M | Sell |
171,789
-1,900
| -1% | -$27.7K | 0.02% | 647 |
|
|
2015
Q3 | $2.17M | Buy |
173,689
+2,900
| +2% | +$39.8K | 0.01% | 714 |
|
|
2015
Q2 | $2.83M | Sell |
170,789
-36,500
| -18% | -$588K | 0.02% | 665 |
|
|
2015
Q1 | $3.31M | Sell |
207,289
-17,900
| -8% | -$296K | 0.02% | 595 |
|
|
2014
Q4 | $3.51M | Buy |
225,189
+33,800
| +18% | +$494K | 0.03% | 606 |
|
|
2014
Q3 | $2.63M | Buy |
191,389
+47,700
| +33% | +$724K | 0.02% | 718 |
|
|
2014
Q2 | $2.31M | Buy |
143,689
+22,700
| +19% | +$359K | 0.02% | 757 |
|
|
2014
Q1 | $2.04M | Buy |
120,989
+80,900
| +202% | +$1.47M | 0.02% | 758 |
|
|
2013
Q4 | $844K | Sell |
40,089
-17,300
| -30% | -$390K | 0.01% | 1236 |
|
|
2013
Q3 | $1.25M | Buy |
+57,389
| New | +$1.22M | 0.01% | 850 |
|
Other funds holding NXGN
Two Sigma Advisers's NXGN Position: Q4 2023 in Review
Two Sigma Advisers sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 330,887 shares — an estimated $7.85M sold.
Two Sigma Advisers first reported a position in NXGN in Q3 2013 and held it in 41 quarters. The position peaked at $7.85M in Q3 2023. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.
- Two Sigma Advisers reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Two Sigma Advisers sold 330,887 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $7.85M.
- Two Sigma Advisers first reported a position in NextGen Healthcare, Inc. Common Stock in Q3 2013 and held it in 41 quarters.
- Two Sigma Advisers's NextGen Healthcare, Inc. Common Stock position peaked at $7.85M in Q3 2023.
- 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.
Based on Two Sigma Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.